(Q30762349)

English

Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

0 references

0 references

author name string

Mari A

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

43-51

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with specific IgE to Phleum pratense

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Complementary DNA cloning and expression of a newly recognized high molecular mass allergen phl p 13 from timothy grass pollen (Phleum pratense).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

What are the important allergens in grass pollen that are linked to human allergic disease?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Multiple pollen sensitization: a molecular approach to the diagnosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

The high molecular mass allergen fraction of timothy grass pollen (Phleum pratense) between 50-60 kDa is comprised of two major allergens: Phl p 4 and Phl p 13

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Detection and quantification of group 4 allergens in grass pollen extracts using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Post-translational modifications influence IgE reactivity to the major allergen Phl p 1 of timothy grass pollen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Molecular, structural, and immunologic relationships between different families of recombinant calcium-binding pollen allergens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01569.X

21 January 2018

Identifiers

10.1046/J.1365-2222.2003.01569.X

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30762349&oldid=1547482578"